{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:48:35Z","timestamp":1791150515285,"version":"4.1.0"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T00:00:00Z","timestamp":1433376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003823","type":"journal-article","created":{"date-parts":[[2015,6,4]],"date-time":"2015-06-04T18:05:13Z","timestamp":1433441113000},"page":"e0003823","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease"],"prefix":"10.1371","volume":"9","author":[{"given":"Paul J.","family":"Converse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Nuermberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques H.","family":"Grosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2217\/fmb.11.101","article-title":"Treating <italic>Mycobacterium ulcerans<\/italic> disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?","volume":"6","author":"PJ Converse","year":"2011","journal-title":"Future Microbiology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e2739","DOI":"10.1371\/journal.pntd.0002739","article-title":"Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial","volume":"8","author":"S Klis","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","article-title":"Pharmacokinetics of rifampicin and clarithromycin in patients treated for <italic>Mycobacterium ulcerans<\/italic> infection","author":"JW Alffenaar","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e2085","DOI":"10.1371\/journal.pntd.0002085","article-title":"Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of <italic>Mycobacterium ulcerans<\/italic> disease","volume":"7","author":"DV Almeida","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e2315","DOI":"10.1371\/journal.pntd.0002315","article-title":"<italic>Mycobacterium ulcerans<\/italic> Disease: Experience with Primary Oral Medical Therapy in an Australian Cohort","volume":"7","author":"ND Friedman","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1371\/journal.pntd.0001473","article-title":"Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of <italic>Mycobacterium ulcerans<\/italic>: An Observational Cohort Study","volume":"6","author":"DP O'Brien","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1517\/14656566.6.16.2867","article-title":"Clarithromycin extended-release in community-acquired respiratory tract infections","volume":"6","author":"KN Williams","year":"2005","journal-title":"Expert opinion on pharmacotherapy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/QAD.0b013e32836268f4","article-title":"Moxifloxacin for Buruli ulcer\/HIV coinfected patients: kill two birds with one stone?","volume":"27","author":"DP O'Brien","year":"2013","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/cid\/ciq072","article-title":"Oral Treatment for <italic>Mycobacterium ulcerans<\/italic> Infection: Results From a Pilot Study in Benin","volume":"52","author":"A Chauty","year":"2011","journal-title":"Clinical Infectious Diseases"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(09)61962-0","article-title":"Antimicrobial treatment for early, limited <italic>Mycobacterium ulcerans<\/italic> infection: a randomised controlled trial","volume":"375","author":"WA Nienhuis","year":"2010","journal-title":"The Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/AAC.02165-13","article-title":"Clinical and Bacteriological Efficacy of Rifampin-Streptomycin Combination for Two Weeks followed by Rifampin and Clarithromycin for Six Weeks for Treatment of <italic>Mycobacterium ulcerans<\/italic> Disease","volume":"58","author":"RO Phillips","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref12","first-page":"43","article-title":"Use of rifapentine and clarithromycin in an all-oral regimen for Buruli ulcer","author":"DV Almeida","year":"2013"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0140-6736(73)92005-9","article-title":"A controlled trial of the treatment of <italic>Mycobacterium ulcerans<\/italic> infection with clofazimine","volume":"2","author":"WD Revill","year":"1973","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"363","author":"WJ Britton","year":"2004","journal-title":"The Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The Continuing Challenges of Leprosy","volume":"19","author":"DM Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"A Van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.201304-0753OC","article-title":"Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice","volume":"188","author":"JH Grosset","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1416951112","article-title":"Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis","volume":"112","author":"S Tyagi","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/AAC.01731-12","article-title":"Multiscale Distribution and Bioaccumulation Analysis of Clofazimine Reveals a Massive Immune System-Mediated Xenobiotic Sequestration Response","volume":"57","author":"J Baik","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkr444","article-title":"Clofazimine: current status and future prospects","volume":"67","author":"MC Cholo","year":"2012","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1936","DOI":"10.1371\/journal.pntd.0001936","article-title":"Clofazimine modulates the expression of lipid metabolism proteins in <italic>Mycobacterium leprae<\/italic>-infected macrophages","volume":"6","author":"Y Degang","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species","volume":"286","author":"T Yano","year":"2011","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from <italic>Mycobacterium ulcerans<\/italic> required for virulence","volume":"283","author":"KM George","year":"1999","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e29774","DOI":"10.1371\/journal.pone.0029774","article-title":"Autoluminescent <italic>Mycobacterium tuberculosis<\/italic> for Rapid, Real-Time, Non-Invasive Assessment of Drug and Vaccine Efficacy","volume":"7","author":"T Zhang","year":"2012","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e2598","DOI":"10.1371\/journal.pntd.0002598","article-title":"Rapid, Serial, Non-invasive Assessment of Drug Efficacy in Mice with Autoluminescent <italic>Mycobacterium ulcerans<\/italic> Infection","volume":"7","author":"T Zhang","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1371\/journal.pntd.0000985","article-title":"BCG-Mediated Protection against <italic>Mycobacterium ulcerans<\/italic> Infection in the Mouse","volume":"5","author":"PJ Converse","year":"2011","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/AAC.01260-10","article-title":"Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with <italic>Mycobacterium ulcerans<\/italic> Infection","volume":"55","author":"T Zhang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/JB.187.5.1668-1676.2005","article-title":"Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of <italic>Mycobacterium ulcerans<\/italic>","volume":"187","author":"TP Stinear","year":"2005","journal-title":"J Bacteriol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1128\/AAC.46.10.3193-3196.2002","article-title":"Bactericidal activity of rifampin-amikacin against <italic>Mycobacterium ulcerans<\/italic> in mice","volume":"46","author":"H Dega","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/AAC.36.3.548","article-title":"Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice","volume":"36","author":"J Grosset","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e2618","DOI":"10.1371\/journal.pntd.0002618","article-title":"Accelerated Detection of Mycolactone Production and Response to Antibiotic Treatment in a Mouse Model of <italic>Mycobacterium ulcerans<\/italic> Disease","volume":"8","author":"PJ Converse","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.5694\/j.1326-5377.2009.tb03313.x","article-title":"&quot;Paradoxical&quot; immune-mediated reactions to <italic>Mycobacterium ulcerans<\/italic> during antibiotic treatment: a result of treatment success, not failure","volume":"191","author":"DP O'Brien","year":"2009","journal-title":"The Medical journal of Australia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1371\/journal.pntd.0001252","article-title":"Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?","volume":"5","author":"M-T Ruf","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref34","article-title":"Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline","author":"AH Diacon","year":"2015","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e1290","DOI":"10.1371\/journal.pntd.0001290","article-title":"Spontaneous clearance of <italic>Mycobacterium ulcerans<\/italic> in a case of Buruli ulcer","volume":"5","author":"CL Gordon","year":"2011","journal-title":"PLoS Negl Trop Dis"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T01:52:18Z","timestamp":1599097938000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003823"}},"subtitle":[],"editor":[{"given":"Richard O.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,4]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003823","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,4]]}}}